Articles published by Allarity Therapeutics, Inc.
Allarity Therapeutics Announces 1-for-20 Reverse Stock Split
April 04, 2024
Via GlobeNewswire
Tickers
ALLR
Allarity Therapeutics Reports Full Year 2023 Financial Results and Provides a Business Update
March 08, 2024
Via GlobeNewswire
Tickers
ALLR
Allarity Therapeutics to Present at Biomarkers 2024
February 28, 2024
Via GlobeNewswire
Tickers
ALLR
Allarity Therapeutics to Present at Biomarkers Europe 2023
October 02, 2023
Via GlobeNewswire
Tickers
ALLR
PLOS ONE Publishes Data on Allarity Therapeutics’ DRP® Companion Diagnostic for Dovitinib
August 30, 2023
Via GlobeNewswire
Tickers
ALLR
Via GlobeNewswire
Tickers
ALLR
Via GlobeNewswire
Tickers
ALLR
Allarity Therapeutics Announces Clarification of Effective Date for Reverse Stock Split
June 27, 2023
Via GlobeNewswire
Tickers
ALLR
Via GlobeNewswire
Tickers
ALLR
Via GlobeNewswire
Tickers
ALLR
Via GlobeNewswire
Tickers
ALLR
Via GlobeNewswire
Tickers
ALLR
Allarity Therapeutics Reschedules 2022 Annual Stockholders Meeting and Sets New Record Date
December 01, 2022
Via GlobeNewswire
Tickers
ALLR
Allarity Therapeutics Reports Third Quarter 2022 Financial Results
November 15, 2022
Via GlobeNewswire
Tickers
ALLR
Allarity Therapeutics Announces Adjournment of 2022 Annual Meeting of Stockholders
November 07, 2022
Via GlobeNewswire
Tickers
ALLR
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.